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Background: The determinants and barriers for delivery and uptake of IPTp vary with different regions in sub-Saharan
Africa. This study evaluated the determinants of ANC clinic attendance and IPTp-SP uptake among parturient women
from Mount Cameroon Area and hypothesized that time of first ANC clinic attendance could influence uptake
of IPTp-SP/dosage and consequently malaria parasite infection status at delivery.
Methods: Two cross sectional surveys were carried out at the Government Medical Centre in the Mutengene
Health Area, Mt Cameroon Area from March to October 2007 and June 2008 to April 2009. Consented parturient
women were consecutively enrolled in both surveys. In 2007, socio-demographic data, ANC clinic attendance,
gestational age, fever history and reported use/dosage of IPTp-SP were documented using a structured questionnaire.
In the second survey only IPT-SP usage/dosage was recorded. Malaria parasitaemia at delivery was determined by blood
smear microscopy and placental histology.
Results and discussion: In 2007, among the 287 women interviewed, 2.2%, 59.7%, and 38.1% enrolled in the first,
second and third trimester respectively. About 90% of women received at least one dose SP but only 53% received
the two doses in 2007 and by 2009 IPTp-two doses coverage increased to 64%. Early clinic attendance was associated
(P = 0.016) with fever history while being unmarried (OR = 2.2; 95% CI: 1.3-3.8) was significantly associated with fewer
clinic visits (<4visits). Women who received one SP dose (OR = 3.7; 95% CI: 2.0-6.8) were more likely not to have
attended ≥ 4visits. A higher proportion (P < 0.001) of women with first visit during the third trimester received only
one dose, meanwhile, those who had an early first ANC attendance were more likely (OR = 0.4; 95% CI = 0.2 - 0.7)
to receive two or more doses. Microscopic parasitaemia at delivery was frequent (P = 0.007) among women who
enrolled in the third trimester and had received only one SP dose than in those with two doses.
Conclusion: In the study area, late first ANC clinic enrolment and fewer clinic visits may prevent the uptake of two
SP doses and education on early and regular ANC clinic visits can increase IPTp coverage.
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Antenatal care is an important component of maternal and
child health care to monitor the health of the mother,
anticipate difficulties and complications of labour, ensure
the birth of a healthy baby and to help the mother rear the
child [1]. Infrequent, late or non-attendance at antenatal
care clinics has been associated with adverse maternal out-
come [2]. Malaria in pregnancy remains a major public
health problem in endemic areas of the African region,
where approximately 25–30 million of pregnant women are
at risk of Plasmodium falciparum infection and its adverse
outcomes during their pregnancy [3,4]. To reduce malaria
burden in pregnancy, the World Health Organization
(WHO) currently recommends a package of interventions
in areas with stable (high) transmission of P. falciparum [4].
These include the use of insecticide-treated nets (ITNs),
intermittent preventive treatment (IPT) and effective case
management of malaria illness and anaemia. Currently,
sulphadoxine-pyrimethamine (SP) is the most effective
drug for IPT despite the increasing resistance of SP to P.
falciparum [5,6]. Intermittent preventive therapy with SP
for malaria in pregnancy (IPTp-SP) in areas of high or sea-
sonal transmission have been shown to lower placental in-
fection rates, increase both maternal haemoglobin levels
and the infants’ birth weight [7,8].
A high proportion of pregnant women in Africa attend
ANC clinic at least once during pregnancy thus the
antenatal clinic provides a good opportunity for deliver-
ing interventions to control malaria in pregnancy in en-
demic regions. Studies conducted in Malawi and Kenya
showed that the maximum benefit of IPT can be gained
by receiving two doses or more (in HIV infected preg-
nant women) doses of SP. More so, majority of women
who received a minimum of two doses of SP do attend
four or more ANC visits [9]. Despite a high ANC clinic
attendance in most countries in Sub-Africa, reported
coverage level of IPTp-SP and ITNs remains below the
reversed Abuja Declaration target of 80% [10].
The determinants and barriers for delivery and uptake
of IPT and ITN vary with different regions [11]. Meta-
analysis of factors affecting the delivery, access, and use
of interventions to prevent malaria in pregnancy in sub-
Saharan Africa identified education, knowledge and percep-
tion about malaria [12,13], socio-economic status [14-17],
number and timing of antenatal clinic visits [12,17],
number of pregnancies, healthcare system issues [13,17]
as factors that influence intervention coverage as well as
access to ANC services. While most reports on ANC
clinic attendance and IPTp/SP coverage are from stud-
ies carried out in West and East Africa, reports from
Central Africa are limited [17].
In 2007, about 90% of women in Mount Cameroon
Area attending ANC clinic received IPTp-SP at least
once during pregnancy, but only 52% of these womenhad the recommended two or more doses [18]. To iden-
tify facilitating factors for scaling up IPTp-SP coverage
in the study area, this study evaluated the determinants
of ANC clinic attendance and IPTp-SP uptake among par-
turient women who seek delivery services at the Mutengene
Medical Centre. The study hypothesized that time of first
ANC clinic attendance could influence uptake of IPTp-SP/
dosage and consequently malaria parasite infection status
among pregnant women at delivery.
Methods
Study area and population
This study consists of two cross sectional surveys carried
out at the Government Medical Centre in the Mutengene
Health Area, Mt Cameroon Area, Southwest Region from
March to October 2007 and June 2008 to April 2009. The
Mutengene Medical Centre is the only government owned
institution that offers antenatal care, preventive and cura-
tive services at subsidized costs in the health area. The
characteristics of the study area have been described else-
where [18]. In brief, malaria transmission is perennial, with
some seasonality. Pregnant women in this semi-urban area
of Cameroon are frequently (62%) exposed to P. falciparum
infection during pregnancy with placental malaria parasit-
aemia rate of 34% at delivery. History of fever attack is
common (44%) in women during pregnancy [18]. Previous
studies show that anaemia is still a major health problem in
this area [18-20]. Consecutive pregnant women reporting
for delivery at the Mutengene maternity and who con-
sented to participate in the study were enrolled.
Administration of questionnaires
During the first survey, a total of 287 parturient women
were interviewed. A structured questionnaire was ad-
ministered to women to document socio-demographic
data including age, residence, marital status and educa-
tional level. Antenatal data were obtained from either
the antenatal card or the register of the centre with
assistance of a midwife and included: parity, gestational age
at first ANC, number of ANC visits made. Gestational age
was determined after the physical examination by the mid-
wife who used a gestational calendar or uterine growth
when the date of last menses was not known. Fever history,
use of IPTpSP (dosage and dates of drug administration)
was recorded from ANC cards, patient’s medical record
book and health centre maternal care register. During the
second survey, only IPTp-SP usage/dosage was recorded
for 292 pregnant women at ≥ 36 weeks of gestation.
Sample collection and processing
Maternal peripheral venous blood (2 ml) was collected
within 24 hours after delivery for malaria parasite detec-
tion. Immediately following delivery, the placenta was
obtained and a small piece of placental tissue (0.5 cm3)
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pression smears. A larger (4 cm3) biopsy specimen of
placental tissue was fixed in 10% neutral buffered forma-
lin for histopathological assessment as described else-
where [18].
Parasitological examination
Peripheral blood was used to prepare thick blood smears
and together with placental impression smears stained with
Giemsa (Sigma) and examined by light microscopy. Placental
tissue sections were processed, stained with haematoxylin
and eosin and examined. Placental malaria parasitisation was
determined as reported elsewhere [18].
Definitions and data analysis
All data were entered and analysed using SPSS version
19. Age and parity was categorized as follows: age (≤20,
21–25, >25) years; parity (primiparae, secundiparae and
multiparae (≥3 pregnancies). The Complete ANC attend-
ance was considered to be at least four ANC visits during
pregnancy. A full course IPTp/SP was defined as at least a
complete two-dose course of SP administered during the
pregnancy. Malaria infection was defined as the presence
of parasites detected by peripheral blood, placental blood
microscopy and placental histologic examination further
classified as microscopic and submicroscopic infection.
Differences between groups were assessed using chi-
square or Fisher’s exact tests for proportions and student
t-test for means. The factors that influence ANC clinic
attendance and IPTp-SP uptake were assessed using odds
ratio and the 95% confidence interval (OR (95% CI)
determined in univariate analysis and logistic regression in
multivariate analysis. Correlations were assessed using Pear-
son correlation test. A p-value of less than 0.05 was consid-
ered significant. The study received ethical clearance from
the Delegation of Public Health Ethics Review Board, Buea,
Southwest Region.
Results
Characteristics of study participants
The characteristics of parturient women who partici-
pated in the study in 2007 are shown in (Table 1). Their
ages range from 14–40 years with a median age and parity
of 23(20–27) years and 2(1–3) births respectively. There
was strong positive correlation (r = 0.796; P < 0.001) be-
tween age and parity of all mothers, where primiparous
mothers (19.6 ± 2.7 years) were significantly younger (p <
0.001) compared to multiparous mothers (25.8 ± 4.7 years).
The study population was predominantly made up of mar-
ried women (75.1%); and 62.3% of the women were edu-
cated to primary level and only 4.5% and 6.4% had tertiary
level and no formal education respectively. It is noted that
59.2% (125/211) of the married women were housewives
and engaged in no occupation while 52.2% (35/67) of theunmarried mothers were students or applicants. At deliv-
ery, the median gestational age of 39 (38–40) weeks and
neonatal birth weight of 3.20 (3.00-3.60) kg respectively
were recorded.
Antenatal care attendance
Of the 287 participating women, 96.5% reported attend-
ing ANC at least once during their last recent preg-
nancy. Antenatal clinic visits varied from 1–12 with
a median of 5 visits. Among ANC attendees, majority
(60%) made their first visit in the second trimester
(Table 2). Approximately 91% of the women made more
than one visit and only 69.3% of the ANC attendees had
complete attendance (considered to be at least four
ANC visits during pregnancy) (Table 2). Women who
had a complete ANC attendance were significantly older
(P = 0.038) when compared with those who did fewer
ANC visits. Also married women frequently made four
or more visits than unmarried women. Thus younger age
(≤20 years) (OR = 2.0; 95% CI: 1.2-3.4) and being unmarried
(OR = 2.2; 95% CI: 1.3-3.8) were significant risk factors
associated with fewer clinic visits (<4visits). Fever history
was associated with more ANC clinic visits (OR = 0.51, 95%
CI 0.30 - 0.89) (Table 3) as women with fever history
Table 2 Antenatal care visit attendance and IPTp-SP
usage of parturient women (N = 287)
Characteristics % (n)
ANC visit at least once 96.5 (277)
ANC visit at least twice 94.2 (261)
ANC visit at least thrice 84.1 (233)
≥ 4 ANC visits 71.8 (199)
Median No. of ANC visits (quartiles) 5 (3–6)
Non-ANC attendance 3.5 (10)
First ANC visit; Median GA (range)
1st trimester 2.2 (06) 12 (8–12)
2nd trimester 59.7 (160) 21 (14–25)
3rd trimester 38.1 (102) 29 (26–37)
IPTp-SP usage 90.5 (258/285)
SP dosage
Two or more 53.1 (136)
One 46.9 (120)
No IPTp-SP 9.5 (27)
Trimester of 1st SP dose
1st trimester 0.8 (2)
2nd trimester 59.8 (150)
3rd trimester 39.4 (99)
GA = Gestational age (weeks).
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for first ANC clinic visit when compared with those
with no fever history (25.00 ± 4.80 weeks). In multivariate
analysis, marital status (unmarried) (p = 0.006) and fever
history (P = 0.009) remained significant independent factors
associated with ANC visit attendance (Table 3).
To further investigate the timeliness of ANC attend-
ance, a categorization of ‘early first attendance’ was de-
fined as a first visit to ANC at or before 4 months
gestation. Of all respondents only 18.7(50/268) had
attended ANC at or before four months of gestation.
Women with a fever history were likely (60.0% vs 40.0%;
χ2 = 5.841; P = 0.016) to make an early first ANC visit
than those without fever history. No other determinants
of early attendance were identified.
IPTp uptake at ANC clinic
Sulphadoxine-pyremathmine treatment was presumptive
and administered at an ANC. Among ANC attendees,
90.5% reported receiving at least one dose of SP during
pregnancy. However, only 53.1% (136/256) received two
or more doses of IPT-SP at an ANC visit. Among
women who received SP at least once, only 59.8% re-
ported taking the first dose within the second trimester
(19-22weeks) while 39.4% of women received it during
the 3rd trimester (26-30weeks) and rarely (0.8%) during
the first trimester (<16 weeks) (Table 2). The timing offirst IPTp dose within the study population as shown in
Figure 1 demonstrates that when IPTp was given, it was
generally first given from fourth month of gestation
and majority of the women received SP between the fifth
and sixth months. This is consistent with the WHO
guidelines for delivery of IPTp, which recommends the
delivery of first IPT dose at each scheduled visit after
‘quickening’ (16 weeks) to ensure that a high proportion
of women received a minimum of two doses of IPT [3].
Furthermore the timing of first IPT dose correlated sig-
nificantly (r = 0.919; P < 0.001) with the timing of first
attendance at ANC clinic (Figure 1).
The proportion of women receiving the recommended
2 or 3 doses of IPTp-SP increased (p < 0.001) with the
number of ANC visits attended (Table 3). Thus women
who received one dose (OR = 3.7) were more likely not
to have attended four or more visits (Table 3). More so,
there was a significant (p = 0.004) association between
early first ANC attendance and SP dosage where women
who had an early first ANC attendance were more likely
(OR = 0.4; 95% CI = 0.2 - 0.7) to receive the recom-
mended two or more SP doses. There was no significant
association between age, parity, marital status and IPTp-
SP uptake at an ANC. From 2008–2009, a follow-up
study showed an increase in IPTp-SP coverage to 93.5%
(for women who had received at least one dose) and to
64.1% for those who had received complete IPT (two
doses) (Figure 2).
Association between trimester of first ANC visit, SP
dosage and malaria parasite infection status at delivery
A significantly higher (P < 0.001) proportion of women
with first ANC visit during the third trimester received
only one SP dose during pregnancy compared with those
who had two or more doses (Table 4). Equally, the preva-
lence of microscopic malaria parasitaemia was significantly
higher (P = 0.029) among parturient women with first clinic
visit during the third trimester when compared with those
who enrolled in their second trimester of pregnancy
(Table 4). Nonetheless the association between trimes-
ter of enrolment and malaria parasitaemia at delivery
was only significant among women who had one SP
dose. Thus microscopic parasitaemia at delivery was signifi-
cantly higher (χ2 = 9.938; P = 0.007) among women who
had first ANC attendance in the third trimester and had
received one dose (60.9%) or no SP (21.7%) compared to
those who had two or more doses (17.4%).
Discussion
This study assessed the determinants of ANC clinic at-
tendance and IPTp-SP uptake among parturient women
who seek delivery services at the Mutengene Medical
Centre, Cameroon to identify facilitating factors for scal-
ing up IPTp-SP coverage/dosage in the study area. Also
Table 3 Relationship between ANC visits, individual factors and use of IPTp
Factor ≤ 3visits ≥ 4visits *Significance level
(χ 2; p-value)
#OR (95% CI) †OR (95% CI) P-value
% (n) 95% CI % (n) 95% CI
Age (years)
7.670; 0.022
≤20 40.7 (35) 30.9 – 51.3 25.8 (51) 20.2 – 32.3 2.0 (1.2 – 3.4) 2.0 (1.0 – 4.4) 0.069
21-25 34.9 (30) 25.7 – 45.4 36.4 (72) 30.0 – 43.2 0.9 (0.6 – 1.2) 1.5 (0.7– 3.2) 0.254
>25 24.4 (21) 16.6 – 34.5 37.9 (75) 31.4 – 44.8 REF
Parity
0.765;0.682
Primiparous 34.1 (30) 25.0 – 44.4 29.2 (58) 23.3 – 35.8 1.3 (0.7 – 2.2) 1.2 (0.6 – 2.6) 0.671
Secundiparous 28.4 (25) 20.0 – 38.6 29.2 (58) 23.3 – 35.8 1.0 (0.6 – 1.7) 1.4 (0.7 – 2.8) 0.327
Multiparous 37.5 (33) 28.1 – 47.9 41.7 (83) 35.1 – 48.7 REF
Marital status
7.693; 0.006Unmarried 35.6 (31) 26.4 – 46.1 20.2 (40) 15.2 – 26.3 2.2 (1.3 – 3.8) 2.5 (1.3 – 4.6) 0.006
Married 64.4 (56) 53.9 –73.6 79.8 (158) 73.7 – 84.8 REF
Educational level
3.740; 0.291
None 3.8 (3) 1.2 –10.5 7.6 (14) 4.6 – 12.3 0.5 (0.1 – 1.7) 0.8 (0.1 – 5.1) 0.827
Primary 70.0 (56) 59.2 – 78.9 58.9 (109) 51.7 – 65.8 1.6 (0.9 – 2.9) 1.4 (0.4 – 5.5) 0.594
Secondary 21.3 (17) 13.7 – 31.4 29.2 (54) 23.1 – 36.1 0.7 (0.4 – 1.2) 0.8 (0.2 – 3.3) 0.780
Tertiary 5.0 (4) 2.0 – 12.0 4.3 (8) 2.2 – 8.3 REF
Fever history
Yes 32.5 (26) 23.2 – 43.4 48.4 (93) 41.5 – 55.5
5.829; 0.016
0.5 (0.3 – 0.9) 0.5 (0.3 – 0.8) 0.009
No 67.5 (54) 56.6 – 76.8 51.6 (99) 44.5 – 58.5 REF
IPTp-SP dosage
one 70.3 (45) 58.2 – 80.1 39.1 (75) 32.4 – 46.1
18.824; 0.001
3.7 (2.0 – 6.8) NA
Two or more 29.7 (19) 19.9 – 41.8 60.9 (117) 53.9 – 67.6
*Determined by Chi-square (Fischer exact) Test; #determined from Confidence interval calculator, †determined by multinominal logistic regression, OR = Odd ratio, CI = Confidence interval, Values in bold indicate



































First attendance at ANC (n=268)
First IPTp received (n=251)
Figure 1 Comparison of timing of first attendance at antenatal clinic with timing of first dose of IPTp in the Mutengene Medical Centre.
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ANC clinic attendance, IPTp-SP dosage and malaria
parasitaemia at delivery. The study shows a high cover-
age of ANC attendance in the Mount Cameroon Area,
which ranged from one to twelve visits with a median of
five visits. The WHO recommendation of four ANC
visits was met by more than 70% of the interviewed
women. These findings indicate a high rate of antenatal
care utilization in the study area, similar to that ob-
served in Gabon [17] and Tanzania [21] and offers the
potential for implementing the nationally recommended
approaches to the prevention and control of malaria [9].
This high attendance can be explained by the fact that
Mutengene Medical Centre is the only public health
facility that offers antenatal care, preventive, curative
and delivery services at affordable costs when compared
with the private medical centres in the health area. In
Cameroon, in several health centres and public hospitals,
health care services have been made affordable for the
middle and low-income population since 2007. Intermit-
tent preventive treatment with SP is freely provided to
the mothers and is most often available. Evidence from
elsewhere has shown that access to services and costs
are serious barriers to utilization of ANC services among
the underprivileged and thus making such services af-
fordable to the poor is a necessity [22,23]. Although the
timing of ANC was also found to be correct with a large
proportion of women having their first visit during the
second trimester, more than one third (38%) of women
were found to start ANC clinic during the third trimes-
ter. Similar findings have been observed in other African
countries [24]. A majority of women attended ANC at
five months gestation or later and thus represents an op-
portunity for timely delivery of IPTp-SP. More so, the
study showed that the timing of ANC attendance had a
significant effect on the uptake of first SP dose. The first SP
dose was usually administered after first ANC consultation.
In contrast, a previous study in Northeast Tanzania ob-
served that earlier ANC attendance (<20 weeks) had only alimited effect on the uptake of IPTp [25]. Late attendance
for some pregnant women (5%) occurred at or after
32 weeks thus leaving insufficient time for the uptake of a
second dose of SP before giving birth. This is in line with
recent findings in Benin by d’Almeida et al. [26].
Factors affecting ANC clinic attendance have been
reviewed [11]. Women with a fever history were more
likely to make an earlier ANC initiation or more visits
(≥4 visits) in this study suggesting that enrolment and
attendance are delayed (or the opposite promoted) de-
pending on the health status of the pregnant woman. A
study in Tanzania found that having a history of a previ-
ous reproductive loss was a strong predictor for an earl-
ier ANC initiation. Secondly marital status was found to
be an independent factor associated with frequent ANC
clinic visits rather than the timing of the first visit. Simi-
larly, not being supported by the husband or partner
was identified as a factor associated with a later ante-
natal care enrolment in South-eastern Tanzania [21]. On
the contrary, a study in rural Uganda found no significant
association between marital status and ANC utilization
[12]. Findings by Schatz [27] in Malawi have shown that
marriage is an economic necessity for women while studies
in Kenya [28] and Ghana [29] noted that husbands have an
important economic role that influences women’s access to
care. More so, some men perceive it as the husband’s re-
sponsibility to maintain the well-being of his pregnant wife
and to ensure that she attends the ANC. Studies have also
shown that adolescent pregnant girls are less likely to at-
tend an ANC and seek timely care for malaria [29,30].
There was no significant relationship between age and
ANC attendance after adjusting for covariates in explora-
tory analysis. Other authors have reported no association
[21,31].
In 2007, about 90% of women received at least one dose
but only 53% received the recommended two dose SP
regimen. This observed coverage is in range with findings
from other settings. A cross-sectional study in Gabon re-
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1 SP dose
No SP
Figure 2 Overall IPTp intake in parturient women in 2007, 2008–2009 in the Mutengene Medical Centre.
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dose of IPTp/SP and two or more doses of SP were taken
by 57.6% of the women [32]. In 2008–2009, an increase in
the coverage rate of IPT-two doses to 64% was recorded
probably due to continuous awareness campaigns orga-
nized throughout the country. Similarly, in Benin, the rate
of IPT-SP coverage for those who had received complete
IPT increased to 68.4% in 2009 [26]. In the study area, the
delivery of the first IPTp-SP dose was timely, generally be-
tween 16-24weeks, which is in accordance with the WHO
implementation guideline [3]. Firstly, the low coverage of
the second SP dose compared to that of first dose in study
area could be due to fewer ANC visits (≤3visits). Women
who had fewer ANC visits were almost four times likely
not to take the recommended SP dosage. This finding con-
firms reports from Benin and Cameroon where IPT admin-
istration varied with the number of prenatal consultations
[26,33]. Comparable to findings by Bouyou-Akotet et al.
[17] in Gabon, it is noteworthy that 39% of parturient
women with more than three ANC visits had partial SP
uptake which is a evident that several ANC visits does not
necessary ensure complete IPTp uptake, thus identification
of facilitating factors to enhance uptake of complete IPTpTable 4 Association of trimester of first ANC visit with SP dos
Factor/Trimester First % (n) Second
SP dosage
Two or more 33.3 (2) 63.5 (1
One 50 (3) 34.6 (
No SP 16.7 (1) 1.9 (
Malaria infection status
Microscopic& 0 (0) 18.8 (
Submicroscopic# 66.7 (4) 17.5 (
Negative 33.3 (2) 63.8 (1
*Determined by Pearson Chi-square Test; Significance level = P < 0.05.
&Defined as malaria parasitaemia detected by blood smear microscopy and placent
#Defined as malaria parasitaemia detected by placental histology only.dose warrants investigation. Secondly, achievement of full
SP dose was also prevented by late enrolment at the ANC,
frequently delayed until the third trimester and at or after
32 weeks of gestation for certain women, in line with
reports from Benin [26]. This study further shows that
women who attended first ANC clinic in the third trimester
and had one or no SP dose frequently had microscopic
parasitaemia at delivery suggesting that late ANC may have
important implications in the prevalence of malaria parasit-
aemia in women at delivery.
Conclusion
Marital status and fever history independently influenced
ANC clinic attendance while uptake of one SP dose was
associated with late first ANC visit and fewer clinic
visits. Thus earlier ANC clinic attendance may improve
coverage of two or more SP doses in the study area.
Given that about 40% of parturient women who had rec-
ommended number ANC visits (≥4visits) had partial SP
uptake suggests that other factors besides number and
timing of ANC clinic visits affect the delivery, access,
and use of interventions to prevent malaria in pregnancy
in the study area. Thus identification of barriers to theage and malaria infection status at delivery
% (n) Third % (n) *Significance level
01) 28 (28) χ2 = 35.361; p <0.001
55) 62 (62)
3) 10 (10)
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tion. More so, educating pregnant women on focused
ANC clinic visits is recommended.
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